NASDAQ:HSICHenry Schein Stock Price, Forecast & News

Henry Schein's stock was trading at $57.68 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, HSIC stock has increased by 2.4% and is now trading at $59.07. View which stocks have been most impacted by Coronavirus.

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Henry Schein in the last year. There are currently 3 sell ratings, 8 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Henry Schein.

Henry Schein is scheduled to release its next quarterly earnings announcement on Tuesday, August 4th 2020. View our earnings forecast for Henry Schein.

Henry Schein, Inc. (NASDAQ:HSIC) released its quarterly earnings data on Tuesday, May, 5th. The company reported $0.94 EPS for the quarter, beating the Zacks' consensus estimate of $0.74 by $0.20. The business had revenue of $2.43 billion for the quarter, compared to the consensus estimate of $2.32 billion. Henry Schein had a return on equity of 15.19% and a net margin of 7.11%. The company's revenue was up 2.9% compared to the same quarter last year. During the same period in the prior year, the business earned $0.80 earnings per share. View Henry Schein's earnings history.

Henry Schein shares split on Friday, September 15th 2017. The 2-1 split was announced on Wednesday, August 16th 2017. The newly created shares were distributed to shareholders after the market closes on Thursday, September 14th 2017. An investor that had 100 shares of Henry Schein stock prior to the split would have 200 shares after the split.

Henry Schein announced that its board has approved a share repurchase plan on Thursday, October 31st 2019, which authorizes the company to repurchase $400,000,000.00 in shares, according to EventVestor. This repurchase authorization authorizes the company to repurchase up to 4.3% of its shares through open market purchases. Shares repurchase plans are typically a sign that the company's board of directors believes its shares are undervalued.

14 brokerages have issued 12-month target prices for Henry Schein's stock. Their forecasts range from $50.00 to $80.00. On average, they expect Henry Schein's share price to reach $63.73 in the next twelve months. This suggests a possible upside of 7.9% from the stock's current price. View analysts' price targets for Henry Schein.

News coverage about HSIC stock has trended negative on Friday, according to InfoTrie Sentiment Analysis. The research group identifies negative and positive media coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Henry Schein earned a news impact score of -2.8 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View the latest news about Henry Schein.

Some companies that are related to Henry Schein include McKesson (MCK), AmerisourceBergen (ABC), Cardinal Health (CAH), Patterson Companies (PDCO) and Owens & Minor (OMI). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Henry Schein investors own include Alibaba Group (BABA), AbbVie (ABBV), AT&T (T), Walt Disney (DIS), Pfizer (PFE), Intel (INTC), NVIDIA (NVDA), salesforce.com (CRM), Cisco Systems (CSCO) and UnitedHealth Group (UNH).

Henry Schein trades on the NASDAQ under the ticker symbol "HSIC."

Henry Schein's stock is owned by a variety of retail and institutional investors. Top institutional investors include Pensionfund DSM Netherlands (0.02%), Pensionfund Sabic (0.02%) and M&R Capital Management Inc. (0.01%). Company insiders that own Henry Schein stock include David Mckinley, E Dianne Rekow, Gerald A Benjamin, James P Breslawski, Michael S Ettinger, Paul Brons, Philip A Laskawy, Stanley M Bergman, Steven Paladino and Walter Siegel. View institutional ownership trends for Henry Schein.

HSIC stock was sold by a variety of institutional investors in the last quarter, including M&R Capital Management Inc.. Company insiders that have sold Henry Schein company stock in the last year include James P Breslawski, Michael S Ettinger, Paul Brons, Stanley M Bergman, Steven Paladino, and Walter Siegel. View insider buying and selling activity for Henry Schein.

HSIC stock was bought by a variety of institutional investors in the last quarter, including Pensionfund DSM Netherlands, and Pensionfund Sabic. View insider buying and selling activity for Henry Schein.

Shares of HSIC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of HSIC stock can currently be purchased for approximately $59.07.

Henry Schein has a market capitalization of $8.43 billion and generates $9.99 billion in revenue each year. The company earns $694.73 million in net income (profit) each year or $3.51 on an earnings per share basis. Henry Schein employs 19,000 workers across the globe.

The official website for Henry Schein is www.henryschein.com.

Henry Schein's mailing address is 135 DURYEA RD, MELVILLE NY, 11747. The company can be reached via phone at 631-843-5500 or via email at [email protected]